AGI Therapeutics, Inc. Report issue

For profit Phase 3
Founded: Dublin Ireland (2003)
Status: Acquired by Vidara Therapeutics (2014) → now Amgen

Organization Overview

First Clinical Trial
2007
NCT00552565
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

verapamil (calan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Irritable Bowel Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1